$1.08
0.02[1.89%]
At close: Apr 26
$1.08
0[0.00%]
After Hours: 6:19PM EDT
Karyopharm Therapeutics
(NASDAQ:KPTI)Karyopharm Therapeutics Stock (NASDAQ:KPTI), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/29/2024 | KPTI | Karyopharm Therapeutics | FY | 2024 | — | — | — | $140.00M | $160.00M | $152.02M | Get Alert |
| 01/08/2024 | KPTI | Karyopharm Therapeutics | Q4 | 2023 | — | — | — | $33.60M | $33.60M | $37.64M | Get Alert |
| 01/08/2024 | KPTI | Karyopharm Therapeutics | FY | 2023 | — | — | — | $146.00M | $146.00M | $150.03M | Get Alert |
| 11/02/2023 | KPTI | Karyopharm Therapeutics | FY | 2023 | — | — | — | $145.00M | $160.00M | $151.17M | Get Alert |
| 08/02/2023 | KPTI | Karyopharm Therapeutics | FY | 2023 | — | — | — | $145.00M | $160.00M | $150.34M | Get Alert |
| 05/04/2023 | KPTI | Karyopharm Therapeutics | FY | 2023 | — | — | — | $145.00M | $160.00M | $157.37M | Get Alert |
| 02/15/2023 | KPTI | Karyopharm Therapeutics | FY | 2023 | — | — | — | $160.00M | $175.00M | $163.24M | Get Alert |
| 01/09/2023 | KPTI | Karyopharm Therapeutics | Q4 | 2022 | — | — | — | $34.20M | $34.20M | $38.13M | Get Alert |
| 01/09/2023 | KPTI | Karyopharm Therapeutics | FY | 2022 | — | — | — | $157.70M | $157.70M | $161.68M | Get Alert |
| 11/03/2022 | KPTI | Karyopharm Therapeutics | FY | 2022 | — | — | — | $155.00M | $165.00M | $157.23M | Get Alert |
| 08/04/2022 | KPTI | Karyopharm Therapeutics | FY | 2022 | — | — | — | $155.00M | $165.00M | $160.03M | Get Alert |
| 01/11/2021 | KPTI | Karyopharm Therapeutics | FY | 2020 | — | — | — | $108.00M | $109.00M | $98.14M | Get Alert |
| 01/11/2021 | KPTI | Karyopharm Therapeutics | Q4 | 2020 | — | — | — | $35.00M | $36.00M | $24.91M | Get Alert |
FAQ
What is the most recent guidance for Karyopharm Therapeutics (KPTI)?
There have been no specific sales or earnings guidance reported for Karyopharm Therapeutics in recent months.
Browse guidance and forecast on all stocks.